Expression of transforming growth factor-α, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy

Radiotherapy and Oncology

Volumn 63, Issue 3, 2002, Pages 275-283

  Aebersold, Daniel M ^a   Froehlich, Susanne C ^a,b   Jonczy, Maciej ^a,b   Beer, Karl T ^a   Laissue, Jean ^c   Greiner, Richard H ^a   Djonov, Valentin ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiogenesis; Epidermal growth factor receptor; Platelet derived growth factor; Radiotherapy; Transforming growth factor

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; METHOTREXATE; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR ALPHA; PLATELET DERIVED GROWTH FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OROPHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION INJURY; TREATMENT OUTCOME; TUMOR BIOPSY; BIOSYNTHESIS; DISEASE FREE SURVIVAL; METABOLISM; MIDDLE AGED; OROPHARYNX TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA;

DISEASE-FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGE; NEOPLASMS, SQUAMOUS CELL; OROPHARYNGEAL NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; HUMANS; MIDDLE AGED;

EID: 0036023446     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00131-7     Document Type: Article

References (58)

1. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx
2. Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
3. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas
4. Epidermal growth factor receptor expression in primary laryngeal cancer: An independent prognostic factor of neck node relapse
5. Prevention of v-Ha-Ras-dependent apoptosis by PDGF coordinates in phosphorylation of ERK and Akt
6. The effect of ionizing radiation on signal transduction: Antibodies to EGF receptor sensitize A431 cells to radiation
7. Carcinoma of the oropharynx: Local failure as the decisive parameter for distant metastases and survival
8. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers
9. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells
10. Receptors for epidermal growth factor and other polypeptide mitogens
11. Epidermal growth factor
12. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells
13. Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas
14. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer
15. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death
16. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor
17. Molecular approaches to receptors as targets for drug discovery
18. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma
19. EGF receptor phosphorylation is affected by ionizing radiation
20. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: Implications for a standardized scoring system
21. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
22. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
23. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
24. TGF-alpha and EGFR in head and neck cancer
25. Epidermal growth factor sensitizes cells to ionizing radiation by down- regulating protein mutated in ataxia-telangiectasia
26. Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation
27. Signal transduction via platelet-derived growth factor receptors
28. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck
29. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis
30. Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor
31. Epidermal growth factor modifies cell cycle control in A431 human squamous carcinoma cells damaged by ionizing radiation
32. Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma
33. Transforming growth factor alpha: Expression, regulation, and biological activities
34. Role of platelet-derived growth factors in angiogenesis and alveogenesis
35. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa
36. The epidermal growth factor receptor as a target for cancer therapy
37. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody
38. Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy
39. Autocrine signaling through Ras prevents apoptosis in vascular smooth muscle cells in vitro
40. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion
41. Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells
42. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells
43. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer
44. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors
45. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas
46. Transforming growth factor alpha expression as a potential survival prognosticator in patients with esophageal adenocarcinoma receiving high-dose radiation and chemotherapy
47. Molecular mechanisms of radiation-induced accelerated repopulation
48. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
49. Transforming growth factor-alpha: A more potent angiogenic mediator than epidermal growth factor
50. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1
51. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck
52. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis
53. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival
54. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
55. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy
56. Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro
57. The EGFR family and its ligands in human cancer: Signalling mechanisms and therapeutic opportunities
58. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155